Sunday, May 25, 2025
HomeStocksTechnical Analysis: SBC Medical Group Holdings Incorporated (NASDAQ: SBC)

Technical Analysis: SBC Medical Group Holdings Incorporated (NASDAQ: SBC)

Date:

Related stories

​Bintai Kinden Reports FYE2025 Results, Marks Completion of Regularisation Plan

Bintai Kinden Corporation Berhad ("BKCB" or the "Company"; Bursa: BINTAI,...

Advancecon Continues Contract Win Momentum with RM68.5 Million Contract from Sime Darby Property

Advancecon Holdings Berhad (前进控股有限公司) (“Advancecon” or “the Group”) (Bursa:...

AmanahRaya REIT Delivers Strong Q1 FY2025 Performance with 69.0% Growth in Realised Income Before Tax

AmanahRaya Real Estate Investment Trust (“AmanahRaya REIT”) reported its financial...

Orgabio Unveils Encouraging Revenue Growth of 24.85% to RM28.0 Million in Q3 FY2025

Orgabio Holdings Berhad (“Orgabio” or the “Company”) a leading instant...

Advancecon Secures RM47.5 Million Contract for Gerbil Data Centre Development in Port Dickson

Advancecon Holdings Berhad (前进控股有限公司) (“Advancecon” or “the Group”) (Bursa: 5281),...

Neutral Outlook with Key Support at 5.00–5.08
Price Action Analysis

SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is currently trading at 5.08 on the day. Over the past week, the stock has shown consolidation within a narrow range of 5.02–5.13, reflecting a balance between buyers and sellers. The 1-hour chart highlights a lack of decisive momentum, with prices hovering near the $5.08 level, suggesting short-term indecision in the market.

Immediate Support: The 5.00–5.02 zone has emerged as a critical floor, with the stock rebounding from this level multiple times in recent sessions. A sustained break below $5.00 could signal bearish pressure.

Resistance: The upper boundary lies at 5.08–5.13, where the stock has faced selling interest. A close above 5.13 level may retest the previous high in November levels.

Trading volume remains subdued, averaging between 33,950–38,980 shares, consistent with consolidation phases. The absence of significant volume spikes indicates limited institutional participation and reinforces the neutral near-term bias.

While momentum indicators like the Relative Strength Index (RSI) are not explicitly provided, the sideways price action suggests a neutral RSI reading (near 50), aligning with the lack of overbought or oversold conditions.

SBC’s price action reflects a “wait-and-see” approach among market participants. For now, the stock appears anchored near its 5.08 pivot point level. Traders may consider range-bound strategies (e.g., buying near 5.02) until a breakout occurs.

Latest stories